Grant & Eisenhofer has quietly resolved a contentious dispute over allegations that a former firm lawyer, whistleblower attorney Reuben Guttman, poached a client in a lucrative False Claims Act lawsuit against cancer drug manufacturer Celgene Corp.

Those involved in the dispute—Grant & Eisenhofer on one side and, on the other, Guttman, his current Washington, D.C.-based firm Guttman, Buschner & Brooks and whistleblower client Beverly Brown, a former Celgene saleswoman—filed a joint stipulation Tuesday looking to dismiss litigation playing out in Los Angeles federal court. The filing cited a negotiated settlement that would require each side to pay its own attorney fees and costs.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]